Loading...
OTCM
PURE
Market cap8mUSD
Jul 10, Last price  
0.08USD
1D
0.00%
1Q
33.33%
Jan 2017
-90.83%
Name

PURE Biosciences Inc

Chart & Performance

D1W1MN
OTCM:PURE chart
No data to show
P/E
P/S
4.56
EPS
Div Yield, %
Shrs. gr., 5y
8.95%
Rev. gr., 5y
0.56%
Revenues
2m
+4.58%
155,806200,432336,3921,487,464728,2631,436,137464,180812,000820,000550,000729,0001,289,0001,831,0001,774,0001,909,0006,917,0003,927,0001,853,0001,877,0001,963,000
Net income
-3m
L-15.43%
-1,847,130-3,812,916-4,654,877-6,540,319-7,067,317-6,760,284-8,339,110-8,882,000-8,554,000-12,952,000-7,614,000-21,685,000-6,518,000-7,475,000-6,561,000-6,000-2,319,000-3,497,000-3,961,000-3,350,000
CFO
-3m
L-22.79%
-178,603-2,436,443-2,671,984-4,404,628-5,910,102-5,523,039-6,123,661-5,588,000-3,904,000-6,326,000-6,063,000-4,991,000-4,562,000-3,887,000-2,990,000669,000-1,167,000-2,418,000-3,278,000-2,531,000

Profile

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.
IPO date
Aug 08, 1996
Employees
15
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑072023‑072022‑072021‑072020‑072019‑072018‑072017‑072016‑072015‑07
Income
Revenues
1,963
4.58%
1,877
1.30%
1,853
-52.81%
Cost of revenue
1,113
1,203
1,172
Unusual Expense (Income)
NOPBT
850
674
681
NOPBT Margin
43.30%
35.91%
36.75%
Operating Taxes
10
6
Tax Rate
1.48%
0.88%
NOPAT
850
664
675
Net income
(3,350)
-15.43%
(3,961)
13.27%
(3,497)
50.80%
Dividends
Dividend yield
Proceeds from repurchase of equity
3,500
BB yield
-19.73%
Debt
Debt current
Long-term debt
2,949
1,021
Deferred revenue
Other long-term liabilities
Net debt
2,525
(74)
(3,391)
Cash flow
Cash from operating activities
(2,531)
(3,278)
(2,418)
CAPEX
(33)
(81)
Cash from investing activities
(33)
(81)
Cash from financing activities
1,785
1,015
3,500
FCF
1,058
1,063
871
Balance
Cash
424
1,095
3,391
Long term investments
Excess cash
326
1,001
3,298
Stockholders' equity
(135,476)
(132,126)
(128,170)
Invested Capital
135,561
133,419
132,079
ROIC
0.63%
0.50%
0.52%
ROCE
1,000.00%
52.13%
17.42%
EV
Common stock shares outstanding
111,856
111,404
88,835
Price
0.08
-6.12%
0.09
-57.44%
0.20
-52.45%
Market cap
8,926
-5.74%
9,469
-46.62%
17,740
-51.55%
EV
11,451
9,395
14,349
EBITDA
998
791
894
EV/EBITDA
11.47
11.88
16.05
Interest
155
14
6
Interest/NOPBT
18.24%
2.08%
0.88%